Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Auckland Uniservices discovers novel nitrobenzindole prodrugs for treatment of cancer

April 6, 2010

Critical Outcome Technologies reports preclinical data on oral COTI-2 in TNBC model

April 1, 2010

YM BioSciences expands ongoing phase I/II CYT-387 study in myelofibrosis

April 1, 2010

NexMed files IND with FDA for phase II trial of PrevOnco in hepatocellular carcinoma

April 1, 2010

Eisai submits anticancer agent eribulin for approval in Japan, U.S. and Europe

April 1, 2010

SciClone reports topline phase II data on SCV-07 for prevention of oral mucositis

April 1, 2010

Emory University claims new noscapine analogues for cancer therapy

April 1, 2010

MMRF grants awards to Intellikine and Tragara for multiple myeloma therapies

March 31, 2010

Immunovaccine Technologies begins enrollment in phase I trial of DPX-0907 cancer vaccine

March 31, 2010

GSK resubmits Avodart sNDA for prostate cancer to FDA

March 31, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...